These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 9241405)
1. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria. Griffiths P; Smith C; Harvie A Am J Ment Retard; 1997 Jul; 102(1):27-36. PubMed ID: 9241405 [TBL] [Abstract][Full Text] [Related]
2. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction. Seashore MR; Friedman E; Novelly RA; Bapat V Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322 [TBL] [Abstract][Full Text] [Related]
3. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria. White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066 [TBL] [Abstract][Full Text] [Related]
4. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Diamond A; Prevor MB; Callender G; Druin DP Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921 [TBL] [Abstract][Full Text] [Related]
5. [Intellectual development of phenylketonuria children treated early--a longitudinal study. 10 years' concomitant psychological study in The Netherlands]. Slijper FM; Huisman J; Hendrikx MM; Kalverboer AF; van der Schot L Monatsschr Kinderheilkd; 1989 Oct; 137(10):662-5. PubMed ID: 2586531 [TBL] [Abstract][Full Text] [Related]
6. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)]. Thalhammer O; Havelec L; Knoll E; Wehle E Wien Klin Wochenschr; 1977 Oct; 89(20):684-6. PubMed ID: 930099 [TBL] [Abstract][Full Text] [Related]
7. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. Holtzman NA; Kronmal RA; van Doorninck W; Azen C; Koch R N Engl J Med; 1986 Mar; 314(10):593-8. PubMed ID: 3945244 [TBL] [Abstract][Full Text] [Related]
8. [Intellectual development of patients with phenylketonuria; 15-year national screening in The Netherlands]. Huisman J; van der Schot LW; Hendrikx MM; Kalverboer AF; Slijper FM Ned Tijdschr Geneeskd; 1992 Nov; 136(46):2277-81. PubMed ID: 1461293 [TBL] [Abstract][Full Text] [Related]
9. Correlates of intelligence test results in treated phenylketonuric children. Williamson ML; Koch R; Azen C; Chang C Pediatrics; 1981 Aug; 68(2):161-7. PubMed ID: 7267221 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychological function in mild hyperphenylalaninemia. Smith ML; Saltzman J; Klim P; Hanley WB; Feigenbaum A; Clarke JT Am J Ment Retard; 2000 Mar; 105(2):69-80. PubMed ID: 10755172 [TBL] [Abstract][Full Text] [Related]
11. Phenylalanine control and family functioning in early-treated phenylketonuria. Reber M; Kazak AE; Himmelberg P J Dev Behav Pediatr; 1987 Dec; 8(6):311-7. PubMed ID: 3429669 [TBL] [Abstract][Full Text] [Related]
12. Executive functioning in children and adolescents with phenylketonuria. VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394 [TBL] [Abstract][Full Text] [Related]
13. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria. Sharman R; Sullivan K; Young R; McGill J Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250 [TBL] [Abstract][Full Text] [Related]
14. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)]. Knoll E; Wehle E; Thalhammer O Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401 [TBL] [Abstract][Full Text] [Related]
15. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. Landolt MA; Nuoffer JM; Steinmann B; Superti-Furga A J Pediatr; 2002 May; 140(5):516-21. PubMed ID: 12032515 [TBL] [Abstract][Full Text] [Related]
16. Neurocognitive functioning in adults with phenylketonuria: results of a long term study. Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437 [TBL] [Abstract][Full Text] [Related]
17. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
18. Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study. Michals K; Azen C; Acosta P; Koch R; Matalon R J Am Diet Assoc; 1988 Oct; 88(10):1226-9. PubMed ID: 3171015 [TBL] [Abstract][Full Text] [Related]
19. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels. Sharman R; Sullivan K; Young R; McGill J Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592 [TBL] [Abstract][Full Text] [Related]
20. [Phenylketonuria--change in therapeutic strategies. Study of intellectual development and dietary compliance of young phenylketonuria patients]. Weglage J; Fünders B; von Teeffelen-Heithoff A; Ullrich K Fortschr Med; 1993 Nov; 111(31):485-8. PubMed ID: 8276335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]